RE: New Year - resultsYou are right bioboy regarding ANZ. In addition, ANZ is the latest in a list of bph disappointments at the placebo-control stage. So, yes eyes are on PRX; I hope that the difference vs. placebo is really substantial - other wise Protox may be forced to conduct Phase 3 on their own bill to unlock shareholder value.
I predcit January 6th for the NR and the IPSS score difference will be 6 points! Stock will hit $1.25.
That's MY wish list. Happy holidays to all.